Meeting
2017 ASCO Annual Meeting
A re-analysis of the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial accounting for ovarian cancer (OVCA) heterogeneity.
Authors
Sarah Madhu Temkin
Virginia Commonwealth University, Richmond, VA
Sarah Madhu Temkin , Eric A Miller , Goli Samimi , Christine D Berg , Paul Pinsky , Lori M. Minasian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5564)
DOI
10.1200/JCO.2017.35.15_suppl.5564
Abstract #
5564
Poster Bd #
386
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Association of a polygenic risk score with risk of abnormal ultrasound findings and ovarian cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
First Author: Sarah Phillips
Poster
2016 ASCO Annual Meeting
Association of family history and survival in patients with colorectal cancer.
First Author: Dawn Q. Chong
Poster
2023 ASCO Quality Care Symposium
Association of federal and state policies regulating short-term limited duration insurance (STLD) plans and later cancer stage at diagnosis.
First Author: Nuo Nova Nova Yang
Poster
2023 ASCO Breakthrough
The challenge of colorectal cancer (CRC) screening in low and middle-income countries (LMIC): The Brazilian ten year long experience.
First Author: Victor Filogonio